Identification of a prognostic model using immune related genes combined with tumour mutational burden and T cell infiltration in triple-negative breast cancer
{{output}}
Triple-negative breast cancer (TNBC) is one of the most aggressive molecular subtypes of breast cancer and immune-checkpoint blockade therapy has markedly changed the treatment landscape for this malignancy. Tumour-infiltrating lymphocytes (TILs) and tumour mu... ...
